The Latest Breaking News from IQV

A partnership with Nvidia is bound to yield fruitful results for this little-known company.

IQVIA Holdings will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

The company will leverage Nvidia’s prowess in AI to build proprietary models.

IQVIA Holdings has considerably underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

IQVIA Holdings has underperformed the broader market over the past year, but Wall Street analysts are bullish about the stock’s prospects.

With IQVIA Holdings gearing up to release its third-quarter earnings later this month, analysts project a double-digit surge in earnings.

Despite IQVIA Holdings’ underperformance compared to the S&P 500 Index over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

IQVIA Holdings has underperformed the broader market this year, but Wall Street analysts are bullish about the stock’s prospects.

IQVIA Holdings has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.

The increased demand for healthcare services and technological advancements are poised to keep the healthcare industry buoyed in the foreseeable future. Given this backdrop, are medical stocks Danaher Corporation (DHR), IQVIA Holdings (IQV), and Bio-Rad Laboratories (BIO) worth buying now? Read on to find more….

The market turmoil this year, due to the sky-high inflation and the Fed’s hawkish tilt, has led several fundamentally solid large-cap stocks to trade below their intrinsic values. However, we believe quality large-cap stocks Broadcom (AVGO), Abbott (ABT), IQVIA (IQV), Agilent (A), and QUALCOMM (QCOM), which have declined significantly in…